WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.
更新时间：2025-07-11 直达：westvacpharma.com
加入D5渲染器官方中文社区，与全球设计师和创作者互动交流。探索渲染技巧、获取实用教程、分享作品、解答疑问，助力设计灵感和效率提升。
三思泰捷，高新技术企业，是国内较早从事试验技术研发的专业厂家，产品包括各种试验机、拉力机、万能试验机、高温持久蠕变试验机、电液伺服、扭转、冲击试验机等，精而美的经营理念，是您材料测试的可靠伙伴!
中安云科成立于2016年，作为一家全栈式密码产品与密码服务提供商，专注于密码核心技术的革新探索、密码产品的研发、市场推广和服务，致力于为客户提供全方位、一站式的密码服务，积极促进密码技术在关键基础设施领域的深度应用，助力客户构建完善的网络和信息系统密码防护体系。
强力特,紧固件,锻打,热墩,模锻
虚拟专用服务器空间提供商和国家cnnic认证四星级注册商,提供域名注册、域名申请、域名查询、中文顶级域名注册、国际顶级域名注册、云主机、企业邮箱、CA安全证书等丰富的网络产品服务。H20,NvidiaH20,pretrain,finetune,inference,deeplearning,模型预训练,模型微调,模型推理,深度学习,神经网络训练,Deepspeed,英伟达H20,H20租赁,H800,H800租赁,英伟达H800,H800服务器,H20服务器,NvidiaH800,3090,3090租赁,英伟达3090,3090服务器,Nvidia3090,GH100,GH100租赁,英伟达GH100,GH100服务器,NvidiaGH100
无锡宇丰达科技有限公司是专业从事氮气弹簧维修充气生产,模具弹簧生产,型号种类有P2400-16,NP2000-15NP2000-15,GSC38-25等种类齐全质量可靠,欢迎选购.
中国职业病旗下公司：上海寰球工程有限公司，网址:(http://79857.zybw.com),主要频道：公司简介、荣誉资质、公司相册、产品设备、专家风采、学术交流、优惠活动、联系我们!